XGN logo

Exagen (XGN) Company Overview

Profile

Full Name:

Exagen Inc.

Sector:

Healthcare

Country:

United States

IPO:

September 19, 2019

Indexes:

Not included

Description:

Exagen (XGN) is a biotechnology company focused on developing innovative diagnostic tests for autoimmune diseases. Their main product, AVISE, helps doctors diagnose and manage conditions like lupus by providing accurate and timely information, improving patient care and treatment decisions.

Events Calendar

Earnings

Next earnings date:

Mar 18, 2025

Recent quarterly earnings:

Nov 12, 2024

Recent annual earnings:

Mar 18, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Jan 13, 25 Cantor Fitzgerald
Overweight
Jan 3, 25 Canaccord Genuity
Buy
May 14, 24 Cantor Fitzgerald
Overweight
Sep 26, 23 Cantor Fitzgerald
Overweight
Aug 22, 23 Cantor Fitzgerald
Overweight
May 16, 23 Cantor Fitzgerald
Overweight
Mar 22, 23 BTIG
Buy
Nov 17, 22 BTIG
Buy
Nov 15, 22 Canaccord Genuity
Buy
May 13, 22 Keybanc
Overweight

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Exagen?
  • Does Exagen pay dividends?
  • What sector is Exagen in?
  • What industry is Exagen in?
  • What country is Exagen based in?
  • When did Exagen go public?
  • Is Exagen in the S&P 500?
  • Is Exagen in the NASDAQ 100?
  • Is Exagen in the Dow Jones?
  • When was Exagen's last earnings report?
  • When does Exagen report earnings?
  • Should I buy Exagen stock now?

What is the ticker symbol for Exagen?

The ticker symbol for Exagen is NASDAQ:XGN

Does Exagen pay dividends?

No, Exagen does not pay dividends

What sector is Exagen in?

Exagen is in the Healthcare sector

What industry is Exagen in?

Exagen is in the Diagnostics & Research industry

What country is Exagen based in?

Exagen is headquartered in United States

When did Exagen go public?

Exagen's initial public offering (IPO) was on September 19, 2019

Is Exagen in the S&P 500?

No, Exagen is not included in the S&P 500 index

Is Exagen in the NASDAQ 100?

No, Exagen is not included in the NASDAQ 100 index

Is Exagen in the Dow Jones?

No, Exagen is not included in the Dow Jones index

When was Exagen's last earnings report?

Exagen's most recent earnings report was on Nov 12, 2024

When does Exagen report earnings?

The next expected earnings date for Exagen is Mar 18, 2025

Should I buy Exagen stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions